SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $41,000 | +86.4% | 208 | +58.8% | 0.01% | +80.0% |
| Q2 2020 | $22,000 | -56.0% | 131 | -70.0% | 0.01% | -37.5% |
| Q1 2020 | $50,000 | -12.3% | 437 | -14.5% | 0.01% | +14.3% |
| Q4 2019 | $57,000 | +35.7% | 511 | 0.0% | 0.01% | +16.7% |
| Q3 2019 | $42,000 | +281.8% | 511 | +215.4% | 0.01% | +200.0% |
| Q2 2019 | $11,000 | -81.7% | 162 | -80.9% | 0.00% | -81.8% |
| Q1 2019 | $60,000 | +566.7% | 850 | +424.7% | 0.01% | +450.0% |
| Q4 2018 | $9,000 | -25.0% | 162 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $12,000 | +20.0% | 162 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $10,000 | +25.0% | 162 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $8,000 | 0.0% | 162 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | 0.0% | 162 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $8,000 | 0.0% | 162 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $8,000 | -20.0% | 162 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $10,000 | +25.0% | 162 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $8,000 | 0.0% | 162 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $8,000 | +33.3% | 162 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $6,000 | – | 162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |